Talk:Metronomic therapy

Medicine: Hematology-oncology Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force (assessed as Mid-importance).

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Occupational Safety and Health Low‑importance

	This article is within the scope of WikiProject Occupational Safety and Health, a collaborative effort to improve the coverage of articles related to occupational safety and health on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Occupational Safety and HealthWikipedia:WikiProject Occupational Safety and HealthTemplate:WikiProject Occupational Safety and HealthOccupational Safety and Health
Low	This article has been rated as Low-importance on the project's importance scale.

Comment

"Although there have been many cases that metronomic therapy did not create synergy with other therapies, a number of studies have proven the efficacy of metronomic therapy in treatment of intractable breast cancer.[14] In fact, a recent study presented at American Association for Cancer Research (AACR) congress in 2017 announced the effect of metronomic regimens.[15] The study also encourages further studies about finding appropriate regimen and its optimal dosage."

Comment: more detail is needed regarding the citation provided - specifically that the effects are observed via animal models and also in the context of co-deilivery of immune checkpoint inhibitors. The current passage is vague and potentially misleading. — Preceding unsigned comment added by 85.255.236.163 (talk) 14:38, 4 December 2021 (UTC)[reply]